Key Takeaways
-
Only licensed healthcare professionals can prescribe FDA-approved bremelanotide (Vyleesi), including gynecologists, sexual-medicine specialists, primary-care clinicians, and telehealth providers who must conduct a full evaluation first.
-
Bremelanotide is FDA-approved only for acquired, generalized HSDD in premenopausal women; claims of effectiveness for men or postmenopausal women are not supported by the U.S. label.
-
Clinical trials showed bremelanotide improved sexual-desire scores and reduced distress compared to placebo, but did not increase the number of satisfying sexual events, so it's not a guaranteed solution.
-
Compounded bremelanotide products offered by some clinics are not FDA-approved and lack FDA safety and quality review; ask providers specifically whether you're receiving FDA-approved Vyleesi or a compounded version.
-
Common side effects include nausea (affecting 40% of trial participants), flushing, headache, and skin darkening; bremelanotide is contraindicated for people with uncontrolled hypertension or cardiovascular disease.
-
A trustworthy provider takes time to understand your full health picture, reviews medications and conditions affecting libido, discusses realistic benefits and limits, and never promises guaranteed results.
If your desire has dipped and you have started searching for answers, you are in good company. Low libido is common, and it can feel confusing, frustrating, and even a little lonely. The good news? You have options, and talking about them is a great first step.
One question comes up again and again: who provides libido supporting peptides? The short answer is that licensed healthcare professionals do. That can include gynecologists, sexual-medicine specialists, primary-care clinicians, and appropriately licensed telehealth providers. They assess your health, decide if a peptide makes sense for you, and write a prescription when it does.
In this guide, we will walk through who can prescribe these treatments, what the science says, who qualifies, and how to spot a trustworthy provider. We will keep it simple, honest, and free of hype. Whether you are a busy professional, a health optimizer, or simply curious, you will leave knowing what to ask and what to avoid.
What Are Libido Supporting Peptides?
Peptides are short chains of amino acids that act as messengers in your body. If you are new to the topic, our guide on 8 facts that explain what are peptides in 2026 is a friendly place to start. You can also read a general overview of what are peptides from WebMD.
When people say “libido supporting peptides,” they almost always mean one specific medicine: bremelanotide. It is often called PT-141. In the United States, the FDA-approved version is sold under the brand name Vyleesi.
Bremelanotide is a melanocortin-receptor agonist. In plain words, it works on pathways in the brain tied to sexual desire. That makes it different from pills that mainly increase blood flow. For a deeper look, see 9 intimate wellness facts about PT-141 in 2026.
Who Provides Libido Supporting Peptides?
Here is the honest answer. Bremelanotide is a prescription medicine. You cannot buy the FDA-approved version over the counter, and it is not a supplement. A licensed clinician must evaluate you first.
These are the main types of providers who can assess you and prescribe it:
- Gynecologists: They often treat sexual health concerns in women and know your medical history well.
- Sexual-medicine specialists: They focus on desire, arousal, and related concerns.
- Primary-care clinicians: Your regular doctor or nurse practitioner can review your health and discuss options.
- Licensed telehealth clinicians: Online providers can evaluate you by video, review lab work, and prescribe when appropriate.
A pharmacy then dispenses the medicine. Here is a key tip: ask whether you are getting FDA-approved Vyleesi or a compounded preparation. A good provider will tell you clearly.
Where Telehealth Fits In
Telehealth has made peptide care far more convenient. You can meet with a provider from your couch, complete blood work at a local lab, and have your treatment shipped to your door. That is a big win for busy professionals. To see how this works, read Local Clinic vs. Telehealth: Best Peptide Therapy Near You?
Allura Longevity is one telehealth option built around this model. Their licensed providers, led by a board-certified Family Nurse Practitioner, design personalized plans based on your goals and blood work. Care is available in Florida, Georgia, Texas, Connecticut, Indiana, Maryland, New York, and California.
What the FDA Says About Vyleesi
It helps to know exactly what the approval covers. Vyleesi is FDA-approved for acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. That means low desire that is new, shows up in most situations, and causes real distress.
It also has to be a case where the low desire is not better explained by another health condition, relationship problems, or the effects of a medication or substance.
| Topic | What the FDA Label Says |
|---|---|
| Approved use | Acquired, generalized HSDD in premenopausal women |
| Dose | 1.75 mg injected under the skin of the abdomen or thigh |
| Timing | At least 45 minutes before expected sexual activity |
| Daily limit | No more than one dose in 24 hours |
| Monthly limit | No more than eight doses per month |
| Stop rule | Discontinue after eight weeks if symptoms have not improved |
What Do the Clinical Trials Show?
Two Phase 3 trials enrolled roughly 1,247 to 1,267 premenopausal women with HSDD. The FDA label reports 635 women received bremelanotide and 632 received placebo.
Women taking bremelanotide had statistically significant improvements in sexual-desire scores and in distress tied to low desire, compared with placebo. However, there was no difference from placebo in the change in the number of satisfying sexual events.
That detail matters. It means the medicine may help desire and reduce distress, but it is not a magic switch. A trustworthy provider will share both sides of the story and will never promise a guaranteed boost.
Who Is Not Covered by the Approval?
This is where many online claims go too far. Vyleesi is not FDA-approved for men or for postmenopausal women. Some clinics advertise PT-141 for these groups, but the U.S. label does not support that as an established, approved use.
If you are a man looking into sexual wellness, there are other paths worth exploring. Our article on PT-141 vs. Viagra: Which Wins for Men’s Sexual Health? breaks down the differences. You can also explore peptides for men to see what personalized care can look like.
For women, our guide to 6 real treatments for low libido in women covers evidence-based options beyond peptides. You can also browse peptides for women for more on personalized plans.
FDA-Approved vs. Compounded: Why It Matters
Many wellness clinics offer compounded bremelanotide or other peptides. Compounded products are custom-made by a pharmacy. They are not FDA-approved, and the FDA does not review them for safety, effectiveness, or quality before they reach the market.
Whether compounding is allowed also depends on federal and state rules and the exact circumstances. So it pays to ask smart questions. We cover this topic in depth in FDA-Approved vs. Compounded Peptides: What Wins? and 503A vs. 503B: Which Peptide Compounding Wins?
| Feature | FDA-Approved Vyleesi | Compounded Peptide |
|---|---|---|
| FDA review for safety and effectiveness | Yes | No |
| Labeled for HSDD in premenopausal women | Yes | No |
| Prescription required | Yes | Yes |
| Standardized dose | Yes, 1.75 mg | Varies by pharmacy |
| Quality oversight | FDA manufacturing standards | Depends on the pharmacy |
What a Good Provider Will Do Before Prescribing
Low desire is not always a disorder. It becomes HSDD when it causes you distress or strain in your relationships. A responsible provider knows this and takes time to understand your full picture.
Here is what a thoughtful visit often looks like:
- Listen to your story. They ask when your desire changed and how it affects you.
- Review your health history. Conditions like thyroid issues, depression, or hormone shifts can affect libido.
- Check your medications. Some antidepressants and other drugs can lower desire.
- Consider relationship and stress factors. Sleep, stress, and connection all play a role.
- Order lab work when needed. Blood tests can reveal hormone or nutrient issues.
- Discuss options and risks. You hear the benefits, the limits, and the side effects.
That last step is important. If a provider promises a guaranteed libido boost, treat that as a red flag. For more on picking a safe starting point, see How to Start Peptide Therapy Safely and See Real Results.
Side Effects and Safety Basics
Like any medicine, bremelanotide has risks. It can temporarily raise blood pressure, so it is contraindicated for people with uncontrolled hypertension or known cardiovascular disease.
Common side effects include:
- Nausea: This affected about 40% of treated participants in clinical-trial summaries.
- Flushing: A warm, red feeling in the face or body.
- Headache: Usually mild but worth mentioning to your provider.
- Injection-site reactions: Redness or soreness where you inject.
- Skin or gum darkening: A labeled concern that your clinician should discuss with you.
If you want a broader look at safety, read Is Peptide Therapy Safe? What You Really Need to Know. The National Library of Medicine also hosts peer-reviewed research on peptide therapeutics.
How to Find a Qualified Provider
Finding the right clinician does not have to be stressful. Use this simple checklist as you compare options:
- Confirm licensing. Make sure the provider is licensed in your state.
- Ask what product you will receive. Is it FDA-approved Vyleesi or a compounded version?
- Look for a full evaluation. Skip any clinic that prescribes without asking about your health.
- Expect honest talk about risks. Good providers explain side effects and limits.
- Check for follow-up care. Ongoing monitoring helps keep you safe and on track.
Our guides on how to get prescription peptides safely in 2026 and 15 peptide consultation questions to ask in 2026 can help you feel prepared.
How Allura Longevity Approaches Sexual Wellness
At Allura Longevity, care starts with a $50 virtual consultation. You complete blood work through LabCorp, and licensed providers build a customized six-month plan based on your results and goals. Your treatment is delivered to your home, and your team monitors and adjusts your plan as you go.
This approach fits busy schedules and data-driven health goals. It also keeps safety front and center, because your plan is shaped by your own labs, not a one-size-fits-all script. For a deeper look at the broader picture, see 8 Peptide Facts That Redefine Sexual Wellness in 2026.
Final Thoughts on Who Provides Libido Supporting Peptides
So, who provides libido supporting peptides? Licensed clinicians do, after a proper evaluation. The best-established option is bremelanotide (Vyleesi), approved for acquired, generalized HSDD in premenopausal women. Anything beyond that, including use in men or postmenopausal women and many compounded products, sits outside the FDA label.
The takeaway is simple. Look for a provider who listens, tests, explains the risks, and never overpromises. You deserve care that treats you like a whole person, not just a symptom.
Ready to explore your options with a team that puts personalization first? Request a consultation with Allura Longevity today. Spots for new clients are limited each month, so reach out soon or call (813) 510-6277.
FAQs
Q: Who can prescribe bremelanotide (Vyleesi) for low libido?
A: A licensed healthcare professional can prescribe it after an individual assessment. That includes gynecologists, sexual-medicine specialists, primary-care clinicians, and appropriately licensed telehealth providers. It is a prescription medicine, not an over-the-counter supplement.
Q: Is PT-141 the same as Vyleesi, and is it FDA-approved?
A: PT-141 is another name for bremelanotide, and Vyleesi is the FDA-approved brand. Vyleesi is approved for acquired, generalized HSDD in premenopausal women. Compounded bremelanotide marketed by some clinics is not FDA-approved.
Q: Can men or postmenopausal women use bremelanotide for libido?
A: Vyleesi is not FDA-indicated for men or postmenopausal women. Claims that it is an established, approved libido treatment for those groups are not supported by its U.S. label. If that is you, talk with a clinician about other evidence-based options.
Q: How is Vyleesi taken, and what are the side effects?
A: It is a 1.75 mg injection under the skin of the abdomen or thigh, given at least 45 minutes before expected sexual activity, with limits of one dose per day and eight per month. Common side effects include nausea, flushing, headache, and injection-site reactions, and it can temporarily raise blood pressure.
Q: Are compounded libido peptides safe?
A: Compounded products are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality before marketing. Ask your provider exactly what you are receiving and where it is made. A trustworthy clinician will answer those questions openly.
